Coronavirus COVID-19 Information
- Information for patients who have a scheduled test, appointment or telehealth visit
- Information for hospital visitors
- Donations: How you can help
For more information about clinical trials, please visit www.clinicaltrials.gov or contact us directly:
To inquire about any of our studies call 401-793-4317 or email IDResearch@lifespan.org.
The Miriam Hospital clinical trials unit offers the newest treatments for HIV and hepatitis C (HCV) infections. The experienced research staff consists of physicians, nurses, a data manager, a regulatory assistant and laboratory personnel.
We conduct trials offered through the AIDS Clinical Trials Group (ACTG) network, funded by the National Institutes of Health, in association with the Partners/Harvard AIDS Clinical Trials Unit. The priority of ACTG studies is to evaluate new strategies for treating HIV infection and preventing HIV complications, and to evaluate new treatments for hepatitis C.
Other studies offered through our clinical trials unit include pharmaceutical studies to treat hepatitis C, prevent C. difficile infection, and test new methods of diagnosing HIV infection.
Test if pitavastatin can prevent heart disease in HIV positive patients
Evaluate if early treatment helps the body control HIV better and keep HIV from “hiding” in the body.
Evaluate if adding one of two different FDA-approved HIV meds helps improve brain function.
Treatment with an FDA-approved drug to determine if it can help with the long-term affects of HIV infection
Behavioral intervention study
Test investigational medication to prevent HIV and genital herpes.
Compare HIV reservoir in genital tract to HIV in blood.
Test whether using hormonal contraception or creams increases risk of HIV infection in women.
To inquire about any of these studies call 401-793-4317 or email IDResearch@lifespan.org.